Advertisement
Home »

Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).

Apr 22, 2024

ABOUT THE EXPERTS

  • M John

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

    Immunology, PathWest, Murdoch, Western Australia, Australia.

    Medical Genomics IIID, Murdoch University, Murdoch, Western Australia, Australia.

    L Williams

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

    G Nolan

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

    M Bonnett

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

    A Castley

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

    Immunology, PathWest, Murdoch, Western Australia, Australia.

    D Nolan

    Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement